-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qh7NQD6ZEynjyRso7L5-gS
January 15, 2008 - Screening For Illicit Drug Use: Recommendation Statement
1
Screening for Illicit Drug Use
U.S. Preventive Services Task Force Recommendation Statement
• The U.S. Preventive Services Task Force (USPSTF) makes
recommendations about preventive care services for patients without
recognized signs or symptoms of…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
June 09, 2020 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Evidence Summary
Unhealthy Drug Use: Screening
June 09, 2020
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan98/statin-use-in-adults-preventive-medication-november-2016
May 02, 2014 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Research Plan
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication
May 02, 2014
Recommendations made by the USP…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
June 11, 2019 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis
June 11, 2019
Recommendations made by the USPSTF are independ…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening-january-2008
January 15, 2008 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Drug Use, Illicit: Screening
January 15, 2008
Recommendations made by the USPSTF are independent of the U.S. government. They shou…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
June 11, 2019 - Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force
Preexposure Prophylaxis for the Prevention of HIV Infection
Evidence Report and Systematic Review
for the US Preventive Services Task Force
Roger Chou, MD; Christopher Evans, MD…
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cognitive-impairment-older-adults
March 06, 2025 - insurance status, driving privileges, independence)
KQ 5: Serious adverse events (e.g., death, serious adverse … drug reactions), total adverse reactions from medications, withdrawals due to adverse events, and unexpected
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening
June 09, 2020 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Unhealthy Drug Use: Screening
June 09, 2020
Recommendations made by the USPSTF are independent of the U.S. government. They should not be …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
June 09, 2020 - Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Screening for Unhealthy Drug Use
Updated Evidence Report and Systematic Review
for the US Preventive Services Task Force
Carrie D. Patnode, PhD, MPH; Leslie A. Perdue, MPH; Megan Rushkin, MPH; Tra…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
January 01, 2001 - PII: S0749-3797(01)00255-0
Screening and Treating Adults for Lipid Disorders
Michael P. Pignone, MD, MPH, Christopher J. Phillips, MD, MPH, David Atkins, MD, MPH, Steven M. Teutsch,
MD, MPH, Cynthia D. Mulrow, MD, MSc, Kathleen N. Lohr, PhD
Context: Screening and treatment of lipid disorders in people at high risk f…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
April 09, 2001 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001
April 09, 2001
Recommendations made by the USPSTF are independent of the U.…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
August 22, 2023 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Prevention of Acquisition of HIV: Preexposure Prophylaxis
August 22, 2023
Recommendations made by the USPSTF are independent of the U.S. government. They shou…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
July 26, 2017 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Research Plan
Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis
July 26, 2017
Recommendations made by the USPSTF are indep…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/UaT8AVUSVQwSduNs8TA-_e
June 09, 2020 - JAMA
Screening for Unhealthy Drug Use
US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Summary of Recommendations
Importance
Many people in the US experience problems related to unhealthy
drug use, defined in this recommendation statement as the use of
illegal drugs and …
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
July 05, 2005 - therapy at CD4+ T lymphocyte counts of >350 cells/mm 3 : disease progression, treatment durability, and drug … toxicity. … risk for cardiovascular complications and intolerable (causing discontinuation of therapy with the drug … ) side effects from HAART.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
June 20, 2019 - therapy at CD4� T lymphocyte counts of �350 cells/mm3: disease
progression, treatment durability, and drug … toxicity. … risk for cardiovascular complications and
intolerable (causing discontinuation of therapy with the drug … )
side effects from HAART.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening-2007
October 15, 2007 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Blood Pressure in Adults (Hypertension): Screening
October 15, 2007
Recommendations made by the USPSTF are independent of the U.S. government. They …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KSYrhQuAswGjTww_4sDFGZ
December 01, 2007 - Evidence for the Reaffirmation of the USPSTF Recommendaiton on Screening for High Blood Pressure
Evidence for the Reaffirmation of the U.S. Preventive Services Task
Force Recommendation on Screening for High Blood Pressure
Tracy Wolff, MD, MPH, and Therese Miller, DrPH
Background: High blood pressure is common, and …
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
July 15, 2007 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Lipid Disorders in Children: Screening
July 15, 2007
Recommendations made by the USPSTF are independent of the U.S. government. They should…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
December 01, 2003 - Obesity is an increasingly significant U.S. health
problem. Over 4 decades, the prevalence of obesity
(body mass index [BMI], kilograms of weight
divided by height in meters squared [kg/m2], ≥ 30)
has increased from 13% to 31% in adults and the
prevalence of overweight (BMI 25–29.9 kg/m2) has
increased from 31% to 34%.…